• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the June 2, 2010 Meeting of the Antiviral Drugs Advisory Committee

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
 
 
FDA
 
FDA Core Presentations, (BLA) 125283, motavizumab, for the June 2, 2010 Meeting of the Antiviral Drugs Advisory Committee:
 
Debra B. Birnkrant, M.D. Director Division of Antiviral Products (DAVP) OND, CDER, FDA (PDF – 118KB)
 
Alan Shapiro, M.D., Ph.D. Medical Officer DAVP, OND, CDER, FDA (PDF – 272KB)
 
Sponsor
 
MedImmune, LLC, (BLA) 125283, motavizumab, for the June 2, 2010 Meeting of the Antiviral Drugs Advisory Committee: (PDF – 8.73MB):
 
Core Presentation (PDF – 163KB)
 
Question & Answer Slides (PDF – 273KB)